Jacobs Bruce N. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Jacobs Bruce N.（CIK 1821074）在 1 家公司共报告 21 笔 SEC Form 4 内部人交易（最近一笔 2026-07-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 买入 | 61,378 | $327,145 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 1,500 | $165,810 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 1,700 | $189,664 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 1,100 | $124,067 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 4,110 | $469,311 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 51,375 | $5.9M |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 7,971 | $923,178 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 6,153 | $719,862 |
| 2026-07-02 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 3,200 | $376,649 |
| 2026-06-03 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 买入 | 12,653 | $26,318 |
| 2026-05-19 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 买入 | 15,000 | $31,200 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 买入 | 17,650 | $0 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 2,039 | $178,922 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 1,424 | $126,024 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 4,113 | $368,772 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 492 | $41,328 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 2,519 | $214,216 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 1,437 | $123,266 |
| 2026-03-04 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 447 | $38,719 |
| 2025-09-17 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 买入 | 79,220 | $164,778 |
| 2025-09-17 | Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 卖出 | 79,220 | $4.0M |
来源：SEC Form 4 申报文件 · 截至 2026-07-02